The extensive use of per- and polyfluoroalkyl substances (PFASs) in industrial consumer products has led to groundwater contamination, raising concerns for human health and the environment. These persistent chemicals exist in different forms with varying properties, which makes their removal challenging. In this study, we assessed the effectiveness of three different β-cyclodextrin (β-CD) adsorbents at removing a mixture of PFASs, including anionic, neutral, and zwitterionic compounds, at neutral pH. We calculated linear partition coefficient (Kd) values to quantify the adsorption affinity of each PFAS. β-CD polymers crosslinked with hexamethylene diisocyanate (β-CD-HDI) and epichlorohydrin (β-CD-EPI) displayed some adsorption of PFASs. Benzyl chloride β-CD (β-CD-Cl), an adsorbent that had not been previously reported, was also synthesized and tested for PFAS adsorption. β-CD-Cl exhibited higher PFAS adsorption than β-CD-HDI and β-CD-EPI, with log Kd values ranging from 1.9 L·g−1 to 3.3 L·g−1. β-CD-Cl displayed no affinity for zwitterionic compounds, as opposed to β-CD-HDI and β-CD-EPI, which removed N-dimethyl ammonio propyl perfluorohexane sulfonamide (AmPr-FHxSA). A comparison between Kd values and the log Kow of PFAS confirmed the significant role of hydrophobic interactions in thee adsorption mechanism. This effect was stronger in β-CD-Cl, compared to β-CD-HDI and β-CD-EPI. While no effect of PFAS charge was observed in β-CD-Cl, some influence of charge was observed in β-CD-HDI and β-CD-EPI, with less negative compounds being more adsorbed. The adsorption of PFASs by β-CD-Cl was similar in magnitude to that of other adsorbents proposed in literature. However, it offers the advantage of not containing fluorine, unlike many commonly proposed adsorbents.
Chlorinated volatile organic compounds (CVOCs) are often found in combination with 1,4-dioxane which has been used as a solvent stabilizer. It would be desirable to separate these compounds since biodegradation of 1,4-dioxane follows an aerobic pathway while anaerobic conditions are needed for biodegrading CVOCs. Conventional adsorbents such as activated carbon (AC) and carbonaceous resins have high adsorption capacities for 1,4-dioxane and CVOCs but lack selectivity, limiting their use for separation (Liu et al., 2019). In the current work, two macrocyclic adsorbents, β-CD-TFN and Res-TFN, were examined for selective adsorption of chlorinated ethenes in the presence of 1,4-dioxane. Both adsorbents exhibited rapid adsorption of the CVOCs and minimal adsorption of 1,4-dioxane. Res-TFN had a higher adsorption capacity for CVOCs than β-CD-TFN (measured linear partition coefficient, Kd 2140 −9750 L⋅kg−1 versus 192–918 L⋅kg−1 for 1,1, DCE, cis-1,2-DCE and TCE, respectively) and was highly selective for CVOCs(TCE Kd ~117 Kd for 1,4-dioxane). By comparison, TCE and 1,4-dioxane adsorption on AC was approximately equal at 100 µg⋅L−1 and approximately 1/3 of the adsorption of TCE on the Res-TFN. The greater adsorption and selectivity of Res-TFN suggest that it can be used as a selective adsorbent to separate CVOCs from 1,4-dioxane to allow separate biodegradation.
Food allergies arise when environmental factors, lifestyle choices, and genetic predispositions affect the integrity of the gut epithelial barrier. Under healthy conditions, gut microbiota supports intestinal tight junction integrity and promotes immune tolerance to dietary allergens. Disruption of this microbiota increases susceptibility to epithelial barrier leakage, thereby enabling food allergens to penetrate the bloodstream from the gut and leading to allergic sensitization. Restoring gut homeostasis through allergen-specific immunotherapy (AIT), executed via oral termed as oral immunotherapy (OIT), skin as subcutaneous immunotherapy (SCIT), or under the tongue in the form of sublingual immunotherapy (SLIT), remains a promising yet complex and multifaceted approach. In parallel, probiotics offer a simpler alternative to reinforce epithelial barrier function, restore cellular homeostasis, mitigate allergy symptoms, and represent the probiotics-based OIT. Recently, several bioengineering strategies have been developed toward enriching gut microbiota, such as using additives such as carbohydrates, polyphenols, and probiotics. While generic probiotics have shown efficacy, their undefined dosages and administration protocols pose challenges for clinical standardization in the form of OIT. Emerging developments include recombinant probiotics engineered to express the specific allergen in a controlled manner inside the gut. However, safety concerns regarding their clinical application remain under active discussion. This review highlights various bioengineering strategies to enhance the probiotic capacity, address safety considerations, and explore future prospects for managing food allergies.